JP2002543151A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002543151A5 JP2002543151A5 JP2000615040A JP2000615040A JP2002543151A5 JP 2002543151 A5 JP2002543151 A5 JP 2002543151A5 JP 2000615040 A JP2000615040 A JP 2000615040A JP 2000615040 A JP2000615040 A JP 2000615040A JP 2002543151 A5 JP2002543151 A5 JP 2002543151A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- polypeptide
- antibody
- composition according
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13249899P | 1999-05-04 | 1999-05-04 | |
| US13323899P | 1999-05-07 | 1999-05-07 | |
| US14893999P | 1999-08-13 | 1999-08-13 | |
| US60/148,939 | 1999-08-13 | ||
| US60/132,498 | 1999-08-13 | ||
| US60/133,238 | 1999-08-13 | ||
| PCT/US2000/012041 WO2000066156A1 (en) | 1999-05-04 | 2000-05-04 | Death domain containing receptor 5 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002543151A JP2002543151A (ja) | 2002-12-17 |
| JP2002543151A5 true JP2002543151A5 (cg-RX-API-DMAC10.html) | 2007-05-31 |
Family
ID=27384298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000615040A Pending JP2002543151A (ja) | 1999-05-04 | 2000-05-04 | 死ドメイン含有レセプター5 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1196191A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2002543151A (cg-RX-API-DMAC10.html) |
| AU (1) | AU4817200A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2369371A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2000066156A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7528239B1 (en) | 1997-02-13 | 2009-05-05 | Immunex Corporation | Receptor that binds trail |
| US6342369B1 (en) | 1997-05-15 | 2002-01-29 | Genentech, Inc. | Apo-2-receptor |
| US7279160B2 (en) | 2000-05-02 | 2007-10-09 | The Uab Research Foundation | Combinations of DR5 antibodies and other therapeutic agents |
| TWI318983B (en) | 2000-05-02 | 2010-01-01 | Uab Research Foundation | An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| US7476383B2 (en) | 2000-05-02 | 2009-01-13 | The Uab Research Foundation | Antibody selective for DR4 and uses thereof |
| KR100932577B1 (ko) * | 2001-05-18 | 2009-12-17 | 기린 홀딩스 가부시키가이샤 | 항 trail-r 항체 |
| US7348003B2 (en) | 2001-05-25 | 2008-03-25 | Human Genome Sciences, Inc. | Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors |
| MXPA03010747A (es) | 2001-05-25 | 2004-03-02 | Human Genome Sciences Inc | Anticuerpos que se unen inmunoespecificamente a receptores de ligando inductor de apoptosis relacionado con factor de necrosis tumoral. |
| US7361341B2 (en) | 2001-05-25 | 2008-04-22 | Human Genome Sciences, Inc. | Methods of treating cancer using antibodies that immunospecifically bind to trail receptors |
| EP1439225A4 (en) | 2001-10-04 | 2005-10-26 | Kansai Tech Licensing Org Co | DR5-GEN PROMOTER AND SIAH-1-GEN PROMOTER |
| WO2004085479A2 (en) * | 2003-03-26 | 2004-10-07 | Apogenix Gmbh | Treatment of viral infections |
| BRPI0509201A (pt) | 2004-03-23 | 2007-08-28 | Biogen Idec Inc | agentes de acoplamento de receptor e usos terapêuticos destes |
| WO2005114187A2 (en) * | 2004-04-23 | 2005-12-01 | The United States Of America As Represented By Thesecretary, Department Of Health And Human Services | Methods and compositions for diagnosing aids and other diseases and conditions involving immune system activation |
| BRPI0606791A2 (pt) | 2005-02-02 | 2010-02-09 | The Uab Research Foundation | métodos de reverter ou prevenir a resistência de uma célula a um agonista do receptor da morte, de triar uma célula quanto a um biomarcador da resistência a um agonista do receptor da morte, de monitorar a resistência a um agonista do receptor da morte em um indivìduo, de induzir seletivamente a apoptose em uma célula alvo expressando um receptor da morte, de tratar de um indivìduo com cáncer, de tratar de um indivìduo com uma doença inflamatória ou autoimune, de bloquear a ligação da proteìna contendo card a um receptor da morte em uma célula, de bloquear a associação de um iap com o receptor da morte e de triar um modulador de uma proteìna contendo card, composição, ácido nucleico isolado, vetor, célula, e, polipeptìdeo isolado |
| PE20071101A1 (es) | 2005-08-31 | 2007-12-21 | Amgen Inc | Polipeptidos y anticuerpos |
| CA2780130A1 (en) | 2009-11-05 | 2011-05-12 | The Uab Research Foundation | Treating basal-like genotype cancers |
| US8703712B2 (en) | 2010-03-18 | 2014-04-22 | The Uab Research Foundation | Targeting cancer stem cells with DR5 agonists |
| WO2013148877A1 (en) * | 2012-03-28 | 2013-10-03 | Amgen Inc. | Dr5 receptor agonist combinations |
| ES2812208T3 (es) | 2013-03-14 | 2021-03-16 | Bristol Myers Squibb Co | Combinación de un agonista de DR5 y un antagonista de anti-PD-1 y métodos de uso |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010010924A1 (en) * | 1997-03-14 | 2001-08-02 | Keith Charles Deen | Tumor necrosis factor related receptor, tr6 polynecleotides |
| NZ508381A (en) * | 1997-03-17 | 2002-09-27 | Human Genome Sciences Inc | Antibodies, antagonists and agonists of the death domain containing receptor 5 (DR5) |
| WO2000073349A1 (en) * | 1999-05-28 | 2000-12-07 | Genentech, Inc. | Dr4 antibodies and uses thereof |
| ATE330972T1 (de) * | 1999-06-09 | 2006-07-15 | Genentech Inc | Apo-2l rezeptor-agonist und cpt-11 synergie- effekt |
| TWI318983B (en) * | 2000-05-02 | 2010-01-01 | Uab Research Foundation | An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
-
2000
- 2000-05-04 JP JP2000615040A patent/JP2002543151A/ja active Pending
- 2000-05-04 AU AU48172/00A patent/AU4817200A/en not_active Abandoned
- 2000-05-04 WO PCT/US2000/012041 patent/WO2000066156A1/en not_active Ceased
- 2000-05-04 EP EP00930329A patent/EP1196191A4/en not_active Withdrawn
- 2000-05-04 CA CA002369371A patent/CA2369371A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250313634A1 (en) | Novel anti-pd-l1 antibodies | |
| JP4764627B2 (ja) | 新生物疾患又は免疫不全を処置するためのヒト化免疫調節性モノクローナル抗体 | |
| AU2001295490B2 (en) | Antibodies to human IL-1beta | |
| JP5179689B2 (ja) | 抗体ベース融合タンパク質の循環系内半減期の増強 | |
| US7771723B2 (en) | Remedies for myeloma to be used together with nitrogen mustard antitumor agents | |
| EP0633931B1 (en) | Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon | |
| US20180162944A1 (en) | Novel anti-pd-l1 antibodies | |
| CN112552399B (zh) | 抗sars-cov-2中和抗体 | |
| JP2002544172A5 (cg-RX-API-DMAC10.html) | ||
| JP2022536114A (ja) | 抗ceacam5モノクローナル抗体およびその調製方法およびその使用 | |
| CN111494626A (zh) | 用于治疗il-4和/或il-13介导的信号转导相关的疾病的药物组合物 | |
| EP1470159A2 (en) | Antibody to latent membrane proteins and uses thereof | |
| WO2011137687A1 (zh) | 一种抗癌胚抗原抗体及其应用 | |
| CN106243225A (zh) | 新型抗-pd-l1抗体 | |
| EP1159003B1 (en) | Anti-tnf alpha antibodies in therapy of steroid resistant asthma | |
| CN121263449A (zh) | Cd19/cd38多特异性抗体 | |
| CA2240834C (en) | Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines | |
| US8679483B2 (en) | High-yield method for the production of human antibodies blocking the biological activity of a human cytokine | |
| US12583935B2 (en) | Anti-human CD47 antibody and antigen-binding fragment thereof, and preparation method therefor and use thereof | |
| CN114409766B (zh) | 一种eb病毒的中和性抗体及其应用 | |
| CA2199940C (en) | Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites | |
| Xiang et al. | Targeting gamma interferon to tumor cells by a genetically engineered fusion protein secreted from myeloma cells | |
| CN116063512B (zh) | 多功能重组抗体及其制备方法和应用 | |
| US20050169910A1 (en) | Growth blocking agents | |
| KR20250127148A (ko) | 항-인터류킨-6 항체 투여에 의한 심근염의 치료 |